Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597323 · ClinicalTrials.gov registry record
Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture
A clinical trial, sponsored by Candela Corporation.
- Completed
- Registry status
- 61
- Enrollment target
NCT01597323: Completed study, sponsored by Candela Corporation.
NCT01597323 is a clinical trial that has completed, run by Candela Corporation. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01597323 has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Evaluate the clinical performance, safety and efficacy, of a Radiofrequency and Laser/Light based device for the treatment of facial wrinkles.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2011-10-25 |
| Est. Completion | 2014-10-14 |
What the finished NCT01597323 record still lists
NCT01597323 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01597323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01597323 about?
NCT01597323 is a clinical study titled "Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture". Evaluate the clinical performance, safety and efficacy, of a Radiofrequency and Laser/Light based device for the treatment of facial wrinkles.
What is the current status of trial NCT01597323?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2011-10-25. Estimated completion is 2014-10-14.
Who is sponsoring clinical trial NCT01597323?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI